Advanced Track Psychotropic Long-Acting Injectable Program

Peer-to-Peer: Dig Into the Intricacies of LAI Management and Break Down Barriers to Expand Access to LAIs

Long-acting injectable (LAI) medications are essential maintenance treatment options for bipolar disorder, schizophrenia, and substance use disorders. However, barriers to accessing these medications exist due in part to lack of provider training, administrative support, and billing challenges. This program is designed to extend the knowledge gained from AAPP’s Psychotropic Long-Acting Injectable Training Program by focusing on the intricacies of LAI management and addressing the barriers to their use.

This multi-faceted activity combines pre-recorded presentations with live peer-to-peer virtual networking sessions, offering in-depth education into gaining leadership support for LAI clinics, increasing patient volume, making LAI clinics profitable, transitions of care considerations, management of complex treatment plans, dosing and administration pearls, and integrating LAI administration education into precepting and pharmacy school curriculum. Helpful resources accompany each module to equip pharmacists with the tools necessary to lead, innovate, and advance LAI patient care and clinic management.

Disclosure on State Training Requirements

The ability of a pharmacist to administer injectable medications is based on individual state regulations. Each state has its own unique LAI training requirements. Please review the regulations for the state you practice in to determine what type of training is required prior to administering LAI medications to patients.

Register for the entire LAI advanced training program for FREE!

View AAPP's Core Psychotropic Long-Acting Injectable Training Program

Blended Learning Experience: Pre-recorded Presentations & Interactive Virtual Networking

This full ACPE approved educational activity includes 3 hours of pre-recorded presentations (to be launched in May 2024) that accompany 6 hours of live, peer-to-peer virtual networking sessions. The peer-to-peer networking sessions serve as extensions to the pre-recordings. Watch the pre-recorded presentations prior to participating in the virtual networking sessions and come prepared, ready to ask questions, and to participate in more in-depth conversation with faculty and peers. Expert faculty elaborate on the pre-recorded content, answer questions, and engage learners in discussion while offering advanced insight into complex administrative and clinical topics. The virtual networking sessions are recorded and made available to learners who are unable to participate live. ACPE credit can be earned separately for each module. Each module (pre-recording + virtual networking) offers 1.5 CE hours for a total of 9 CE hours earned by completing the full program.

This activity is supported by educational grants from Indivior, Inc., Janssen Scientific Affairs, LLC, and Otsuka America Pharmaceutical, Inc. and Lundbeck.

***Note: Indivior discontinued the sales of Perseris® effective July 9, 2024. Perseris® is included in course materials to accommodate facilities that are still using the remaining supply of this product and for historical reference purposes. While Perseris® may no longer be commercially available, its inclusion in the course is intended to provide comprehensive education.

	Gaining Leadership Support for Long-Acting Injectable Clinics and Increasing Patient Volume Live Peer-to-Peer Virtual Networking Session on July 1, 2024 from 4:00-5:00 CST   Kori Miller, PharmD Patient Care Services Manager Albertsons Companies Pharmacies; Billings, MT
	Making a Long-Acting Injectable Clinic Profitable Live Peer-to-Peer Virtual Networking Session on August 5, 2024 from 4:00-5:00 CST   Alberto Augsten, PharmD, MS, BCPP, DABAT Pharmacy Clinical Manager, Long-Acting Therapy Clinic (LAT) Manager, PGY2 Psychiatric Pharmacy Residency Director, Board Certified Clinical Toxicologist Memorial Regional Hospital; Hollywood, FL
	Inpatient Considerations for Psychotropic Long-Acting Injectable Medications and Transitions of Care Live Peer-to-Peer Virtual Networking Session on September 9, 2024 from 4:00-5:00 CST   Nicolle Dambly, PharmD, BCPP Advanced Clinical Pharmacy Specialist – Psychiatry Jefferson Health New Jersey; Cherry Hill, NJ
	Pearls on Psychotropic Long-Acting Injectable Dosing, Administration, and Treatment Plan Modifications Live Peer-to-Peer Virtual Networking Session on October 7, 2024 from 4:00-5:00 CST   Danielle Moses, PharmD, BCPP Clinical Psychiatric Pharmacist SSM Heath - St. Louis University Hospital; Adjunct Faculty at University of Health Sciences and Pharmacy & St. Louis University; St. Louis, MO
	Management of Complex Psychotropic Long-Acting Injectable Cases Live Peer-to-Peer Virtual Networking Session on November 4, 2024 from 4:00-5:00 CST   Jordan Haygood, PharmD, BCPP Clinical Pharmacy Specialist – Psychiatry Medical University of South Carolina; Charleston, SC
	Integrating Long-Acting Injectable Administration Education into Precepting and Pharmacy Curriculum Live Peer-to-Peer Virtual Networking Session on December 2, 2024 from 4:00-5:00 CST   Megan Ehret, PharmD, MS, BCPP Professor and Co-Director of the Mental Health Program University of Maryland School of Pharmacy; Baltimore, MD

Add Live Sessions to Your Calendar

You must be signed in as a member to view the Live Peer-to-Peer Virtual Networking Session dates.

Courses